Obesity R&D in 2024 & beyond: Key considerations in an increasingly competitive landscape
Published on June 5, 2024
Obesity has undoubtedly become a major area of focus for drug developers over the years, due to its increased prevalence across the globe as well as its debilitating comorbidities, such as cardiovascular disease, cancer, and psychiatric disorders. In parallel, advancements in technology have facilitated deeper understanding of the disease and how to treat it effectively, […]